🔎 Trials Near Me

Home › Prostate Cancer › Florida › Orlando

Prostate Cancer clinical trials in Orlando, FL

18 studies for Prostate Cancer are looking for participants at sites in and around Orlando (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

RecruitingPhase 2
  • Orlando Health Cancer Institute, Orlando
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT03866382

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

Recruiting
  • AdventHealth, Orlando
Ages 18 and older · Men · Updated Nov 12, 2026 · NCT06511141

A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer

RecruitingPhase 1
  • Sarah Cannon Research Institute @ Florida Cancer, Orlando
Ages 18 and older · Men · Updated Nov 3, 2026 · NCT05800665

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

RecruitingPhase 3
  • Clermont Oncology Center ( Site 0087), Clermont · 24 mi away
Ages 18 and older · Men · Updated Oct 30, 2026 · NCT06925737

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

RecruitingPhase 2
  • AdventHealth Medical Group Oncology Research at Celebration, Kissimmee · 16 mi away
Ages 18 and older · All sexes · Updated Oct 26, 2026 · NCT06172478

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

RecruitingPhase 1/2
  • Research Site 137, Orlando
  • Research Site 118, Celebration · 17 mi away
Ages 18 and older · All sexes · Updated Oct 21, 2026 · NCT05914116

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

RecruitingPhase 3
  • AdventHealth, Orlando
Ages 18 to 100 · Men · Updated Oct 15, 2026 · NCT06855277

Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer

RecruitingPhase 1/2
  • Research Site, Orlando
Ages 18 to 99 · Men · Updated Oct 14, 2026 · NCT07590934

Exploring the Potential of Robotic Telesurgery in Remote Settings

Recruiting
  • AdventHealth, Celebration · 17 mi away
Ages 18 to 90 · Men · Updated Oct 8, 2026 · NCT07130708

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

RecruitingPhase 1/2
  • Advent Health, Orlando
Ages 12 and older · All sexes · Updated Oct 2, 2026 · NCT04585750

High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

RecruitingPhase 2
  • Orlando VA Medical Center, Orlando, FL, Orlando
Ages 18 and older · Men · Updated Sep 17, 2026 · NCT05011383

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

RecruitingPhase 2
  • Orlando VA Medical Center, Orlando, FL, Orlando
Ages 18 and older · Men · Updated Sep 17, 2026 · NCT04038502

A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors

RecruitingPhase 1
  • Florida Cancer Specialists & Research Institute, Orlando
Ages 18 and older · All sexes · Updated Jan 12, 2026 · NCT07181473

Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots

RecruitingObservational studyHealthy volunteers welcome
  • Adventhealth, Orlando
Ages 18 and older · All sexes · Updated Nov 17, 2025 · NCT07231159

PET Scan Study to Detect Prostate Cancer in Patients with Early PSA Recurrence

RecruitingPhase 2
  • AdventHealth, Orlando
Ages 18 and older · Men · Updated Oct 24, 2024 · NCT06617481

About Prostate Cancer

Prostate cancer is one of the most common types of cancer among American men. The risk goes up as men age. Learn about symptoms, tests, and treatment.

More about Prostate Cancer on MedlinePlus

Prostate Cancer trials in other cities

Other studies in Orlando

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.